736969-67-8

Basic information

• Product Name: 4-O-acetyl-2,3,6-tri-O-benzyl-α,β-D-glucopyranosyl trichloroimidate
• Synonyms: 4-O-acetyl-2,3,6-tri-O-benzyl-α,β-D-glucopyranosyl trichloroimidate
• CAS NO: 736969-67-8
• Molecular Weight: 636.957
• Mol File: 736969-67-8.mol

Chemical Properties

• CAS DataBase Reference: 4-O-acetyl-2,3,6-tri-O-benzyl-α,β-D-glucopyranosyl trichloroimidate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-O-acetyl-2,3,6-tri-O-benzyl-α,β-D-glucopyranosyl trichloroimidate(736969-67-8)
• EPA Substance Registry System: 4-O-acetyl-2,3,6-tri-O-benzyl-α,β-D-glucopyranosyl trichloroimidate(736969-67-8)

Safety Data

• Hazardous Substances Data: 736969-67-8(Hazardous Substances Data)

Upstream product

• 61236-93-9 1,4-di-O-acetyl-2,3,6-tri-O-benzyl-D-glucopyranoside 
• 19488-48-3 methyl 2,3,6-tri-O-benzyl-D-glucopyranoside 
• 84218-71-3 4-O-acetyl-2,3,6-tri-O-benzyl-β-D-glucopyranoside 
• 545-06-2 trichloroacetonitrile 
• 97974-20-4 (2R,3R,4S,5R,6S)-4,5-Bis-benzyloxy-2-benzyloxymethyl-6-phenylsulfanyl-tetrahydro-pyran-3-ol 
• 19488-48-3 methyl O-2,3,6-tri-O-benzyl-α-D-glucopyranoside 
• 24679-79-6 2,3,6-tri-O-benzyl-D-glucopyranoside 

Downstream Products

• 736969-64-5 (2R,3R,4R)-4-Benzyloxy-N-benzyloxycarbonyl-2-benzyloxymethyl-pyrrolidin-3-yl 4-O-acetyl-2,3,6-tri-O-benzyl-α-D-glucopyranoside 

Relevant articles and documents

Chemical synthesis of 6'''-α-maltotriosyl-maltohexaose as substrate for enzymes in starch biosynthesis and degradation

A branched nonasaccharide 6'''-α-maltotriosyl-maltohexaose was synthesised in 40 steps from D-glucose and maltose. Phenyl O-(2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl)-(1→4)-O-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1→4)-2,3-di-O-benzyl-1-thio-β-D-glucop

Anti-coagulation pentasaccharide and preparing method and medical application thereof

The invention relates to an anti-coagulation medicine, in particular to a synthesized pentasaccharide compound, salt thereof, and a preparing method and medical application of the pentasaccharide compound. The pentasaccharide compound or acid or salt thereof in the ion form shown in the formula III (the formula can be seen in the description) is synthesized and has stronger anti-coagulation factorXa activity and a longer elimination half life compared with sodium sulfonate. The pentasaccharide compound can be used for preparing medicines for preventing and treating blood coagulation disorderrelated diseases such as deep venous thrombosis, thrombophlebitis, artery blockage caused by thrombosis or embolism and postoperative vein thrombosis or embolism.

Anti-coagulation pentasaccharide compound and preparing method and medical application thereof

The invention relates to an anti-coagulation medicine, in particular to a synthesized pentasaccharide compound, salt thereof, and a preparing method and medical application of the pentasaccharide compound. The pentasaccharide compound or acid or salt thereof in the ion form shown in the formula II (the formula can be seen in the description) is synthesized and has stronger anti-coagulation factorXa activity and a longer elimination half life compared with sodium sulfonate. The pentasaccharide compound can be used for preparing medicines for preventing and treating blood coagulation disorder related diseases such as deep venous thrombosis, thrombophlebitis, artery blockage caused by thrombosis or embolism and postoperative vein thrombosis or embolism.

MEDICINAL COMPOSITION CONTAINING DIABETES REMEDY

A pharmaceutical composition effective for the prophylaxis and treatment of, diabetes is provided. This pharmaceutical composition comprises the combination of an α-amylase inhibitor selected from a compound represented by the following general formula (I

OLIGOSACCHARIDE DERIVATIVE

Compounds having the formula (I) : (wherein, A represents a group such as a cyclic group, R1 and R2 represent groups such as alkyl groups or hydroxymethyl groups, and n represents 1 or 2), or pharmacologically acceptable salts thereo